Hawkins Inc HWKN
We take great care to ensure that the data presented and summarized in this overview for HAWKINS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding HWKN
View all-
Black Rock Inc. New York, NY3.16MShares$385 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.47MShares$179 Million0.0% of portfolio
-
State Street Corp Boston, MA781KShares$95.2 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX778KShares$94.8 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA457KShares$55.6 Million0.0% of portfolio
-
Westwood Holdings Group Inc Dallas, TX456KShares$55.5 Million0.45% of portfolio
-
Vaughan Nelson Investment Management, L.P.351KShares$42.7 Million0.37% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT346KShares$42.2 Million0.21% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA314KShares$38.3 Million0.15% of portfolio
-
Bowen Hanes & CO Inc Atlanta, GA307KShares$37.4 Million1.01% of portfolio
Latest Institutional Activity in HWKN
Top Purchases
Top Sells
About HWKN
Hawkins, Inc. blends, manufactures, and distributes chemicals and other specialty ingredients in the United States and internationally. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries. This segment primarily provides acids, alkalis, and food-grade and pharmaceutical salts and ingredients. It also receives, stores, and distributes various chemicals, such as liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide. In addition, this segment manufactures sodium hypochlorite and agricultural products, as well as various food-grade and pharmaceutical products that include liquid phosphates, lactates, and other blended products; repackages water treatment chemicals and bulk industrial chemicals; and performs custom blending of chemicals, and contract and private label bleach packaging. The Water Treatment segment offers chemicals, equipment, and solutions for potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool and agriculture water. The Health and Nutrition segment offers ingredient distribution, processing, and formulation solutions to manufacturers of nutraceutical, functional food and beverage, personal care, dietary supplement and other nutritional food, and health and wellness products. Its products portfolio includes minerals, botanicals and herbs, vitamins and amino acids, excipients, joint products, sweeteners, and enzymes. The company was founded in 1938 and is headquartered in Roseville, Minnesota.
Insider Transactions at HWKN
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 31
2025
|
Douglas A. Lange VP - WATER TREATMENT GROUP |
SELL
Payment of exercise price or tax liability
|
Direct |
2,575
-9.26%
|
$270,375
$105.92 P/Share
|
Mar 31
2025
|
David J. Mangine VP - INDUSTRIAL GROUP |
SELL
Payment of exercise price or tax liability
|
Direct |
2,574
-9.15%
|
$270,270
$105.92 P/Share
|
Mar 31
2025
|
Shirley A. Rozeboom VP HEALTH AND NUTRITION |
SELL
Payment of exercise price or tax liability
|
Direct |
3,152
-8.96%
|
$330,960
$105.92 P/Share
|
Mar 31
2025
|
Drew M. Grahek VICE PRESIDENT OF OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
2,951
-8.24%
|
$309,855
$105.92 P/Share
|
Mar 31
2025
|
Patrick H. Hawkins CEO AND PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
9,549
-3.14%
|
$1,002,645
$105.92 P/Share
|
Mar 31
2025
|
Jeffrey P. Oldenkamp EXECUTIVE VP AND CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,209
-4.77%
|
$441,945
$105.92 P/Share
|
Mar 31
2025
|
Richard G Erstad VP, GENERAL COUNSEL & SEC |
SELL
Payment of exercise price or tax liability
|
Direct |
3,580
-5.6%
|
$375,900
$105.92 P/Share
|
Feb 05
2025
|
Patrick H. Hawkins CEO AND PRESIDENT |
SELL
Bona fide gift
|
Direct |
960
-0.31%
|
-
|
Jan 15
2025
|
Patrick H. Hawkins CEO AND PRESIDENT |
BUY
Bona fide gift
|
Direct |
340
+0.11%
|
-
|
Oct 28
2024
|
Patrick H. Hawkins CEO AND PRESIDENT |
BUY
Bona fide gift
|
Direct |
300
+0.1%
|
-
|
Aug 13
2024
|
Patrick H. Hawkins CEO AND PRESIDENT |
SELL
Bona fide gift
|
Direct |
300
-0.1%
|
-
|
Jul 31
2024
|
Daniel J Stauber |
BUY
Grant, award, or other acquisition
|
Direct |
962
+2.78%
|
-
|
Jul 31
2024
|
James A Faulconbridge |
BUY
Grant, award, or other acquisition
|
Direct |
962
+1.93%
|
-
|
Jul 31
2024
|
Jeffrey E Spethmann |
BUY
Grant, award, or other acquisition
|
Direct |
962
+15.4%
|
-
|
Jul 31
2024
|
Yi Tang |
BUY
Grant, award, or other acquisition
|
Direct |
962
+11.7%
|
-
|
Jul 31
2024
|
Jeffrey L Wright |
BUY
Grant, award, or other acquisition
|
Direct |
962
+2.26%
|
-
|
Jul 31
2024
|
Mary J. Schumacher |
BUY
Grant, award, or other acquisition
|
Direct |
962
+3.63%
|
-
|
Jul 31
2024
|
James T Thompson |
BUY
Grant, award, or other acquisition
|
Direct |
962
+2.5%
|
-
|
Jun 12
2024
|
James A Faulconbridge |
BUY
Open market or private purchase
|
Direct |
1,800
+1.82%
|
$162,000
$90.3 P/Share
|
Jun 11
2024
|
James A Faulconbridge |
BUY
Open market or private purchase
|
Direct |
2,000
+2.14%
|
$176,000
$88.92 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 77.6K shares |
---|---|
Open market or private purchase | 11K shares |
Bona fide gift | 640 shares |
Payment of exercise price or tax liability | 28.6K shares |
---|---|
Bona fide gift | 1.26K shares |